Related Experiment Video
Updated: May 15, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
The progression of bone mineral density loss in dialysis patients compared with the general population
Petar Avramovski1, Aleksandar Sikole
1Department of Internal Medicine and Hemodialysis, Clinical Hospital, Bitola, Republic of Macedonia. avramovski@gmail.com
Insights
Chronic hemodialysis patients experience significantly greater bone mass loss than the general population. This accelerated bone loss, particularly at the hip, is evident even within one month in some patients.
Area of Science:
- Nephrology
- Bone Metabolism
- Geriatrics
Background:
- Chronic hemodialysis patients (CHPs) are at risk for accelerated bone loss.
- General population patients (GPPs) serve as a control for age-related bone density changes.
Purpose of the Study:
- To compare the rate of bone mass loss over 18 months between CHPs and GPPs.
- To identify differences in bone mineral density (BMD) progression between the two groups.
Main Methods:
- Dual-energy X-ray absorptiometry (DXA) was used to measure BMD at the hip and lumbar spine in 80 CHPs and 60 GPPs.
- Biochemical markers including albumin, C-reactive protein, calcium, and parathyroid hormone were analyzed.
- Measurements were taken at baseline and after an 18-month follow-up period.
Main Results:
- CHPs showed a statistically significant progression of hip bone loss (p=0.0002) compared to GPPs (p=0.0577).
- Lumbar spine bone loss progression was not statistically significant in either group (CHP: p=0.5389; GPP: p=0.6820).
- Mean hip BMD decreased from 0.823 ± 0.16 g/cm(2) to 0.769 ± 0.13 g/cm(2) in CHPs over 18 months.
Conclusions:
- Bone mass loss progresses significantly faster in CHPs compared to GPPs.
- Accelerated osteoporosis and bone loss can be observed in CHPs within a short timeframe (1 month).
- These findings highlight the critical impact of chronic hemodialysis on skeletal health.
Background/Aims:
The aim of this study was to compare the progression of bone mass loss in chronic hemodialysis patients (CHPs) with that in general population patients (GPPs) over an 18-month period.
Methods:
The control group consisted of 60 patients (aged 57.5 ± 10.9 years) with a glomerular filtration rate > 60 mL/min/1.73 m(2). The study group included 80 patients undergoing hemodialysis (aged 59.3 ± 11.8 years; duration of dialysis 5.47 ± 5.16 years). Bone mineral density (BMD) testing was conducted in both groups using dual energy X-ray absorptiometry at hip and lumbar spine regions at baseline and after 18 months. Biochemical parameters (albumin, C-reactive protein, calcium, ionized calcium, alkaline phosphatase, and parathyroid hormone) were determined in all participants using standard laboratory procedures.
Results:
The mean values of BMD (average hip + lumbar spine) were 0.900 ± 0.14 g/cm(2) and 0.866 ± 0.14 g/cm(2) in the GPP and 0.823 ± 0.16 g/cm(2) and 0.769 ± 0.13 g/cm(2) in the CHP groups at baseline and 18 months, respectively. The statistical significance (p value) of hip bone loss progression over 18 months was 0.0577 for GPP and 0.0002 for CHP, whereas that of lumbar spine bone loss progression was 0.6820 for GPP and 0.5389 for CHP.
Conclusions:
The of progression bone mass loss was significantly greater in CHP than in GPP. Bone mass loss was evident even over 1 month, albeit in only the CHP with accelerated osteoporosis.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease II: Clinical Manifestations
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Hemodialysis III: Nursing Management
Diabetic Nephropathy
